BSE filing, NSE: GOKAKTEX. Summary written from the filing by ALFA Finder's alert engine.
Gokak Textiles Ltd: key numbers
- Share price
- ₹61.00
- Market cap
- ₹39.65 Cr
- Revenue (annual)
- ₹80.21 Cr
- Net profit (annual)
- ₹-36.69 Cr
- P/E (TTM)
- -1.4×Sector 49.5×
- Promoter holding
- 73.56%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gokak Textiles Ltd
All →Gokak Textiles Business Update
Gokak Textiles closes its Garment Division, which contributed 9.76% turnover last year. Remaining cutting and stitching operations transfer to the Mills Division at Gokak Falls.
Gokak Textiles Merger & Restructuring
Gokak Textiles confirms closure of its Knitwear Division effective October 2026. Assets will be sold to V.G. Parekh & Co. as per prior agreement.
Gokak Textiles Annual General Meeting
Gokak Textiles held its 20th Annual General Meeting on September 24, 2026. Members voted on standard resolutions regarding financial statements and director re-appointment.
Gokak Textiles Annual General Meeting
Gokak Textiles Limited has issued the Notice for its 20th Annual General Meeting scheduled for September 24, 2026. The meeting will conduct routine business including financial statement adoption.
Gokak Textiles Merger & Restructuring Worth ₹19.5 Cr
Gokak Textiles will close and sell its knitwear unit in Belagavi for Rs. 19.50 Crores. The decision addresses operational unviability in the textile business.
- Value
- ₹19.50 Cr
Gokak Textiles Q1 FY27 Results: Net Loss of ₹4.4 Cr, Loss Narrows
Gokak Textiles Ltd reported revenue from operations of ₹25.4 Cr (+52.1% YoY) and a net loss of ₹4.4 Cr for Q1 FY27.
- Key figure
- Net loss ₹4.4 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.